WINNIPEG, Feb. 11 /CNW/ - Pharmatel Fresenius Kabi Pty Ltd, one of
Australia's fastest growing and most innovative pharmaceutical companies, has
chosen the RIVA System (Robotic IV Automation) - a self-contained unit for
filling IV syringes and bags - from Intelligent Hospital Systems (IH Systems)
to consolidate its IV preparation. Pharmatel Fresenius Kabi will take delivery
of its first RIVA unit in June 2009.
The RIVA System and Pharmatel Fresenius Kabi's continued investment in
specialized sterile facilities are a perfect match for meeting the needs of
leading-edge oncology care providers, according to Kevin McGarry, Chief
Executive Officer of IH Systems. "With two Therapeutic Goods Administration
(TGA) registered aseptic compounding facilities preparing tailor-made
chemotherapy doses each day, Pharmatel Fresenius Kabi knows this field and
knows that the RIVA System is able to meet its very high standards," says Mr.
McGarry. He continues, "We are thrilled to be working with this specialist
company in oncology care.
As the demands for improving patient care and safety increase, health
care facilities are increasingly seeking technologically advanced, cost
efficient solutions, says Jane Arnot, Vice President of Sales and Marketing
with IH Systems. "One of the many attributes of the RIVA System that makes it
so attractive is its flexibility to support the diverse needs of Pharmatel
Fresenius Kabi's clients," shares Ms. Arnot. "The RIVA System is well suited
to compounding individual patient doses of oncology drugs into a range of
diverse container forms including syringes and bags, which is key to
supporting convenient and flexible therapy."
Limitations in conventional clean room technology have provided
challenges for manufacturers of compounded oncology products, says Iain
Rosekilly, Operations Director of Pharmatel Fresenius Kabi. "Since we
identified the RIVA system, Intelligent Hospital Systems has worked tirelessly
with us to develop the technology to fit our business model. Their flexible
and customer centred approach will ensure the successful roll out and
implementation of the project." Mr. Rosekilly continues, "IV Robotics have the
ability to address our market growth requirements, as well as many of the
important safety aspects involved in the aseptic compounding of IV drugs, this
would include increased patient safety by the elimination of dose errors,
furthermore providing increased technician operator safety, RSI and other OH&
RIVA (Robotic IV Automation System) - a self-contained unit for filling
IV syringes and bags - is the first product developed by Winnipeg-based
medical device company Intelligent Hospital Systems. For more information,
please visit www.rivasystem.com.
For further information:
For further information: Jane Arnot, VP Sales and Marketing, (204)